Showing results (211-220 of 232) with videos related to

Sort By:
Pageof 24
Diagnostics (Basel, Switzerland)|August 27, 2021
Thyroid Nodule Characterization: How to Assess the Malignancy Risk. Update of the LiteratureDaniele Fresilli, Emanuele David, Patrizia Pacini, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2024
Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world AnalysisGiorgio Grani, Silvia D'Elia, Efisio Puxeddu, et al.
The Lancet. Diabetes & Endocrinology|May 3, 2025
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statementSophie Leboulleux, Laura Boucai, Naifa Busaidy, et al.
Frontiers in Oncology|April 4, 2022
US-Elastography With Different Techniques for Thyroid Nodule Characterization: Systematic Review and Meta-analysisVito Cantisani, Annalisa De Silvestri, Valeria Scotti, et al.
The Journal of Clinical Endocrinology and Metabolism|February 13, 2014
Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironmentSonia Moretti, Elisa Menicali, Pasquale Voce, et al.
European Thyroid Journal|April 8, 2025
Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study)Giulia Puliani, Marta Bianchini, Carlotta Giani, et al.
Pageof 24